RESEARCH DOSSIER
Endowment Insurance and Maturity Benefit Design
Abstract. Endowment insurance combines two contingent payment promises within a finite contract horizon: a benefit on survival to a specified maturity date and a benefit on death during the insured period. This combination connects mortality pooling to scheduled capital accumulation, making maturity design simultaneously an actuarial problem, an asset-liability problem, a contract-law problem, and a consumer-understanding problem. This monograph examines the documentary definition and principal contractual forms of endowment insurance, derives the survival and death components of expected present value, explains premiums and prospective reserves, compares participating and nonparticipating guarantees, and analyzes surrender, paid-up, bonus, loan, and installment-settlement provisions. Evidence includes the U.S. National Association of Insurance Commissioners' statutory classification and illustration materials; the IFRS Foundation's accounting definitions; European Solvency II and insurance-distribution law; India's 2024 insurance-product regulations and an actual Life Insurance Corporation of India policy wording; Singapore's public financial-education guidance; and UK ombudsman evidence regarding savings endowments. A fully specified 20-year illustrative valuation separates conditional probabilities, discounting, premium equivalence, and reserves from observed insurer experience. The original synthesis identifies a central design dependency: the maturity promise acquires its economic meaning only when survival probability, death-benefit timing, guarantee structure, policyholder options, fund participation, and the informational environment are evaluated together. All numerical exercises use explicitly hypothetical assumptions and do not estimate actual market prices or returns. No new proprietary insurance theory is proposed.
Keywords: Endowment insurance; maturity benefit; pure endowment; life-contingent cash flows; actuarial present value; net premium; prospective reserve; nonforfeiture; surrender value; participating insurance; policyholder bonuses; interest-rate guarantee; life insurance disclosure; IFRS 17; Solvency II; insurance product governance.
Introduction and Research Method
A maturity date is an unusually consequential part of a life-insurance promise. It determines when a surviving policyholder becomes entitled to a stated payment, when the death-contingent protection usually ends, how the insurer invests and reserves for the obligation, and how a household evaluates the use of its premiums. A death benefit is contingent on premature death; a maturity benefit is contingent on survival. Their coexistence gives the contract a different payoff profile from term-only death protection, pure endowment, whole-life protection, and deposit accumulation. The NAIC's SSAP No. 50 classification expressly describes endowment insurance as incorporating savings and life-insurance protection and separates combined endowment from pure endowment. This statutory classification offers a documented point of departure rather than a universal definition of every legally recognized policy worldwide.
The research object is the contractual and economic architecture of life policies that promise a benefit for survival through a specified period and a death-related benefit during that period. The analysis considers fixed-benefit and participating policies, flexible settlement options, early exits, guarantees, selected supervisory controls, and household uses. It excludes a full study of general mortality forecasting, the actuarial mathematics of every life-contingent annuity, comprehensive life-insurer capital regulation, and the entire economics of insurance demand. Those subjects are related scientific domains, but the causal object here is the coupled maturity-and-death benefit.
The evidentiary method is a structured comparison of sources with distinct authority. Contractual obligations are evaluated against actual policy wording, regulatory duties against identifiable legal instruments, accounting characterization against IFRS materials, U.S. statutory classifications against NAIC documents, and consumer outcomes against supervisory and ombudsman material. The empirical component is intentionally modest: a worked hypothetical actuarial contract, sensitivity analysis, and a qualitative comparative test of institutional examples. No proprietary insurer claims, assets, surrender, or mortality data were obtained. Cross-market contrasts therefore support claims about documented design possibilities and regulatory mechanisms, rather than population-weighted estimates of prevalence or profitability.
The analysis distinguishes four kinds of proposition. A contractual proposition describes what an identified policy actually promises. A jurisdictional proposition describes what a legal or professional text requires within its scope. An actuarial proposition follows algebraically from a stated model. An interpretive proposition explains the connection among contractual, behavioral, and economic facts. This division is especially important for endowments because nominal maturity guarantees, projection illustrations, prospective reserves, and realized policyholder investment returns answer different questions. The IFRS 17 key terms distinguish insurance risk, investment components, fulfilment cash flows, and risk adjustments; these distinctions will be used consistently without converting them into a claim that any particular endowment contract has a single mandatory accounting classification in all circumstances.
Definitions, Historical and Documentary Foundation
The contingent structure of endowment insurance
Define an endowment insurance contract as a finite-horizon life policy under which the insurer promises a specified payment when the insured survives to maturity, and another payment upon covered death before maturity, subject to the actual conditions of the contract. The payment amounts may coincide, differ, or contain guaranteed and discretionary layers. Maturity occurs at a contractually specified time or attained age. The principal trigger is survival to that date; a contractual expiry date alone does not guarantee a maturity payment under every life-insurance form.
The NAIC 2026 statutory accounting manual, in SSAP No. 50, paragraph 12, describes both combined endowment and pure endowment: the latter pays on survival alone. This distinction has an exact financial consequence. Pure endowment transfers the risk of surviving to the horizon in exchange for a survival-contingent payment. Combined endowment also supplies earlier death protection. Term insurance generally pays for death during the term without a survival payment, while whole-life insurance primarily provides death cover over the insured lifetime. The NAIC life-insurance overview provides related distinctions concerning whole-life cash values, nonforfeiture provisions, dividends, and the duration of coverage.
The pair of promises may be described using a payment rule. Let T denote the future lifetime of the insured measured from policy inception, n the contract term, D(t) the death benefit at an eligible time t, and M the amount payable at n if survival conditions are met. A simplified endowment payment is D(T) when 0 < T ≤ n, and M when T > n. Contracts must specify how deaths exactly on the boundary are treated; the model's weak and strict inequalities are conventions, not a substitute for wording. A death payout before n normally terminates the ordinary base contract, so the maturity promise is not also paid. Policy riders and settlement provisions can alter the resulting cash flows.
The informational burden arises from the same contingent structure. A stated sum assured might describe the death amount, the maturity amount, a base amount before bonus, or several different values, depending on the form. Policyholder communication must identify the named contingent event, payment recipient, time, guarantee status, premium obligations, surrender consequences, and any reductions for loans or charges. Singapore's public endowment insurance guidance explicitly warns that savings-plus-protection policies can require long commitments and may have early-surrender proceeds below premiums paid.
Principal product families
A nonparticipating endowment can promise a contractually guaranteed maturity amount and a defined death payment. Its investment, credit, reinvestment, expense, and insurance risks are principally borne by the insurer for amounts covered by those guarantees, subject to the insurer's performance and the legal protection framework. Participating endowments add the possibility of bonuses or dividends derived from the experience of a participating fund. Singapore's participating-policy explanation separates guaranteed sums from non-guaranteed bonuses and explains that fund results depend on investment returns, claims, and expenses. Bonus vesting depends on governing terms: a declared reversionary bonus may become guaranteed after declaration, while prospective or terminal bonuses remain contingent.
An anticipated endowment pays portions of the survival benefit at intermediate dates and a residual amount at maturity. A limited-premium endowment stops premium payments before maturity but generally continues coverage under its terms. A single-premium endowment uses a single initial payment. A with-profits endowment may combine base guarantees and discretionary participation in a fund; some historical mortgage-related endowments were sold to accumulate the amount expected to repay interest-only borrowing. These categories describe identifiable benefit and funding designs, not uniform cross-border legal labels. The Singapore endowment product taxonomy expressly distinguishes participating, nonparticipating, and anticipated forms.
Investment-linked life products may also combine protection and maturity-linked investment value, but their account exposure and guarantees need separate treatment. A high expected maturity value shown in a scenario is not necessarily a guaranteed maturity sum. The policyholder may bear substantial market risk even while receiving death cover. For an endowment's scientific classification, the decisive evidence is the written structure of insured and survival contingencies and the allocation of guaranteed and non-guaranteed cash flows.
Documentary evidence from an issued policy form
The Life Insurance Corporation of India lists New Endowment Plan 714 with product identifier 512N277V03 among its endowment products. Its publicly available New Endowment Plan policy wording is a useful concrete case because Part C identifies two different benefits. For an in-force policy, the death benefit before maturity is based on a defined death sum assured plus vested simple reversionary bonuses and a possible final additional bonus; the death sum assured is defined as the higher of the basic sum assured and seven times the annualized premium, subject to an additional premium-based floor. On survival to maturity, the maturity sum assured equals the basic sum assured, with the applicable vested and final bonuses. These are product-specific terms, and their conditions, policy status, options, exclusions, and applicable law must be read together.
This example demonstrates why a researcher cannot substitute a generic 'face value' for a policy's complete benefit schedule. The contract can have one base amount, a higher death minimum, bonus-related increments, and alternative installment settlements. Its maturity settlement option allows payment of all or part of maturity proceeds over specified periods instead of a single lump sum, adding a post-maturity payment structure. The original payment trigger may be survival to the stipulated date; the subsequent settlement obligation has its own contractual characteristics. Accordingly, the form identifies not only benefits but also the temporal transition between insurance coverage and settlement.
Historical and economic position
Endowments have a historical link to long-term family savings and debt-repayment plans. Their development can be examined without assuming that a specific modern contract replicates a nineteenth- or twentieth-century predecessor. UK mortgage endowments provide documentary evidence of the risk attached to using a projected investment-related maturity amount to meet a fixed debt. The Financial Ombudsman Service's savings endowment complaints guidance assesses suitability, risk explanation, and the circumstances under which the policy was sold. A specific mortgage-endowment ombudsman decision records a policy sold in 1998 as a repayment vehicle, with a target value and a documented warning that the final amount sufficient to repay the mortgage was not guaranteed. One complaint file illustrates a mechanism and evidentiary approach; it is not a statistical estimate of the rate of mis-selling or of endowment shortfalls.
In the economics of uncertain lifetime, Yaari's (1965) analysis of life insurance choice provides a foundational intellectual context: mortality creates state-contingent allocation problems between consumption while alive and resources for survivors. Its bibliographic information and subject are verified at the publisher record; the paywalled full article was not reviewed here. Endowment insurance adds a scheduled surviving-policyholder claim to the death-contingent arrangement. Its household value depends on the timing and recipient of benefits, the relative need for protection and savings, alternative financial arrangements, and the distribution of risks across the contract term. This is an interpretation of the contract architecture, not a claim of novelty over the broader insurance-demand literature.
Survival and Death Payoffs
A transparent actuarial decomposition
Set n equal to a positive integer number of years. The insured is age x at issue. Let q_{x+k} be the conditional probability of death during policy year k+1 for someone alive at its beginning, p_{x+k}=1-q_{x+k}, and {}_k p_x the probability of survival for k years. Let v=(1+i)^{-1} for an effective annual discount rate i. Under the simplifying assumption that deaths are paid at the end of their year of occurrence, a death benefit D_k in year k+1 and a maturity benefit M at time n have expected present value
The first term is the death-contingent component and the second is the pure-endowment component. The formula follows directly from mutually exclusive payment events and probability-weighted discounting. It requires assumptions on mortality, interest, timing, benefit amounts, and coverage status. Its use for pricing does not imply that a regulatory reserve or an IFRS 17 fulfilment cash-flow measurement uses the identical mortality basis, discount curve, expenses, or risk margin.
The decomposition also separates two kinds of horizon exposure. A maturity benefit is payable at n only if the insured survives and the contract is in force. A death benefit brings some payments forward when mortality increases. When D_k and M are equal to a fixed B, more early deaths can increase present value because the same nominal amount is paid earlier, although the ultimate insured-event probability may be one under the no-lapse model. When maturity and death amounts differ, the sign of mortality sensitivity depends additionally on their relative size and the rate of discount. Therefore the effect of mortality on a combined endowment cannot be inferred from the survival component alone.
A complete illustrative 20-year calculation
Consider a hypothetical policy issued to a specified insured with the following deliberately simplified assumptions: n=20 policy years; an annual conditional mortality rate q=0.002 at all durations; p=0.998; an effective annual discount rate i=3%; a level death benefit of USD 100,000 paid at the end of the year of death; and a USD 100,000 benefit on survival to the end of year 20. Assume no lapse, expenses, bonuses, taxes, commissions, riders, policy loans, changes of premium, or claim-delay risk. These are invented teaching inputs, not population or insured-life estimates.
Under these assumptions, v=1/1.03 and {}_kp_x=0.998^k. The death-benefit expected present value is USD 2,925.35, while the survival maturity-benefit expected present value is USD 53,194.45, producing combined expected present value of USD 56,119.80. The much larger maturity term follows mechanically from the deliberately low probability of death and the substantial surviving population; it does not mean the death component has little social importance. Indeed, its contingency is precisely the state in which family liquidity needs may be most acute.
The conditional probability of reaching the stipulated maturity date is 0.998^20, approximately 96.075%, while the probability of death during the 20-year period is its complement, approximately 3.925%. The nominal amount payable is USD 100,000 under either eligible event in this simplified contract. The value of expected benefits is lower than that amount because it discounts the payment date and uses the event distribution. The distinction between nominal promise and actuarial present value must remain explicit in sales illustrations, reserve analyses, and consumer comparisons.
Variants and payment timing
If the maturity sum remains USD 100,000 and the death sum changes, only the first component of the basic formula changes; actual premiums and reserves must be recalculated accordingly. A return-of-premium death benefit, for example, may depend on cumulative premiums paid up to death rather than a constant D_k. This makes the death amount path-dependent and requires a year-specific benefit schedule. An endowment paying periodic survival installments has multiple terms of the form v^j{}_jp_x S_j and a residual amount at maturity. These intermediate payments reduce the resources retained for the final payment and may influence future premium or lapse behavior.
For an immediate death payout rather than the end-of-year convention, the actuarial calculation ordinarily requires the distribution of death within each year. A constant-force approximation can be used if justified, but it is a modeling choice. When premiums are monthly and death benefits are paid promptly on verified death, using end-year assumptions indiscriminately can misstate expected cash-flow timing. Similarly, inflation-linked or indexed maturity benefits require a specified rule for determining the final payable amount and potentially stochastic inflation or market variables.
The practical lesson is contractual: product comparisons should present the same benefit dimensions on the same timeline. One policy might promise larger death cover and smaller guaranteed maturity proceeds; another might promise a modest death minimum but a higher survival payment. A third might advertise a high illustrated maturity amount whose non-guaranteed portion depends on a participating fund. Their apparent maturity amounts are not commensurable until the payment conditions and guarantee statuses are matched.
Cross-Market Product Design and Institutional Rules
United States: model regulation, statutory classification, and state implementation
The United States offers a documentary distinction between classification and conduct. The NAIC statutory accounting endowment contract definition identifies the family of policy forms. The NAIC's life insurance illustrations topic explains how representations of guaranteed and nonguaranteed policy values operate under Model #582, subject to applicability and state adoption. The Life Insurance Illustrations Model Regulation requires the relevant illustrated elements to be labeled and relates surrender values, policy loans, and guarantees to the presented values. Model texts are not themselves evidence that every U.S. state has enacted identical operative provisions.
The Actuarial Standards Board's revised ASOP No. 24 took effect for relevant actuarial services on December 1, 2024. It provides professional guidance for actuarial services supporting certifications or representations that illustrated scales conform to applicable NAIC illustration rules or actuarial guidelines. It does not make a projected endowment amount contractually guaranteed. Together, these documents support an analytical separation between product economics, legal enforceability, and the governance of illustrations.
European Union: contract options, distribution, and prudential liabilities
Within the European Union, endowment-like savings and protection arrangements may fall within prudential and insurance-distribution requirements according to their legal status and features. The Insurance Distribution Directive imposes duties concerning customer demands and needs, conduct, information, and—where applicable—insurance-based investment product suitability. The Article 25 product governance rule requires manufacturers to establish product approval processes, define a target market, assess relevant risks, and revisit products. The product monitoring rule, from Delegated Regulation 2017/2358, addresses ongoing review and corrective action where a product may be detrimental to customers.
These rules matter to maturity design because suitability and fair-value concerns unfold over a period much longer than the initial sale. A product that meets a customer's protection objective at issue can later become difficult to sustain if contributions are unaffordable or if a prominent expected maturity amount was misunderstood as guaranteed. Conversely, a policy's suitability cannot be judged from historical returns alone; risk preferences, the death-cover need, liquid alternatives, and the stated goal all matter.
Prudential measurement adds a separate perspective. Solvency II probability-weighted technical provisions and its contractual-options provision compel attention to adverse financial and behavioral conditions. A favorable illustrative return does not lower the legal minimum of a contractual guarantee. Likewise, a prospective accounting profit is neither cash available at maturity nor proof of insurer solvency.
India: specified benefit structures and nonforfeiture protections
India's product-design framework supplies a detailed comparison for non-linked savings insurance. The 2024 IRDAI product regulations distinguish participating from nonparticipating structures and prescribe specified surrender-value principles. The regulations' rule for non-linked nonparticipating individual savings products refers to a guaranteed benefit stated as an absolute amount at inception. Their treatment of participating products addresses asset shares and bonus accruals. These are features of that instrument, subject to later operative amendments and product-specific law, and should not be reported as universal principles of all endowments.
The current published LIC product catalog demonstrates that multiple named endowment plans can coexist under one insurer with different forms and identifiers. The LIC New Endowment Plan conditions identify a particular mixture of death and maturity sums, vested bonuses, premium floors, paid-up conditions, and settlement options. Because different plans can alter death-benefit floors, premium periods, and riders, inferences from this one contract cannot be extended automatically to all Indian products.
Singapore: consumer comprehension and participation
Singapore's MoneySense endowment overview states that participating endowment bonuses can change and that early surrender can result in financial loss. Its term-versus-bundled comparison highlights distinct cash-value and risk-bearing characteristics. These official educational materials offer a particularly clear consumer-facing classification of guaranteed protection, cash value, and non-guaranteed participation. They do not prescribe individual investment decisions or reveal the actuarial pricing of particular insurers' portfolios.
A central comparative finding is that identical marketing nouns can conceal different risk transfers. The words 'savings,' 'guaranteed,' 'maturity,' and 'bonus' have different meanings depending on whether the promise is a minimum contract amount, a projected non-guaranteed value, a vested addition, a return dependent on market performance, or an investment component payable independent of an insured event. International comparison must therefore compare events, amounts, enforceability, and options rather than product names alone.
United Kingdom: suitability and mortgage-endowment experience
The UK Financial Ombudsman Service's savings endowment case guidance addresses suitability and misleading sales material. Its specific 1998 mortgage-endowment complaint record shows how an intended maturity target can differ from a contractual guarantee. The researcher should read the complete decision before inferring the outcome of that individual complaint; the relevant point here is the documented structure of advice, target value, and risk disclosure in the case record. Mortgage-linked endowments illustrate an exposure-matching problem: a household may have a fixed nominal liability at the future date while the policy's actual investment-dependent maturity proceeds remain uncertain.
The general design question is whether the policy supplies a guaranteed payment adequate for its stated purpose or merely a contingent funding path. This question survives changes in country, marketing category, and accounting treatment. It is a stronger analytical basis for comparing maturity policies than historical sales volume or projected return illustrations alone.
Empirical Tests and Comparative Research
Research design and evidentiary boundaries
A scientific evaluation of endowment performance requires data on actual contracts and insured populations. The basic observational unit should identify an issued policy form, issue date, insured age or relevant risk characteristics, term, guaranteed death and maturity sums, premium mode, riders, bonus rules, surrender schedule, loan provisions, and settlement elections. Longitudinal administration data must record premiums due and received, premium holidays, deaths, claims paid, surrender dates and amounts, paid-up conversions, cancellations, and maturity settlements. Investment and fund data are needed to evaluate participating and investment-linked promises. Without linking these variables, comparisons across insurer products risk selection bias and misleading reported returns.
Mortality data must correspond to insured cohorts, underwriting classes, issue ages, durations, and relevant calendar periods. A national life table represents a broader population and is not automatically the insurer's insured-life experience. Endowment contracts may also exhibit selection effects: healthier or wealthier people, households committed to savings, or individuals seeking a tax treatment may enter at different rates. Persistency and lapse may vary with household finances and market interest rates. The cross-market documents reviewed here identify legal structures, but do not provide compatible microdata to estimate these behavioral channels quantitatively.
The value of observed contract outcomes can be measured several ways. For an individual holder, the internal rate of return on premiums and benefits depends on the actual dates and values received, and must be treated as a realized ex-post metric. A surrendering holder has a different payment history than a surviving holder at maturity, and a beneficiary receiving a death claim has a fundamentally different outcome. For an insurer, profitability must include risk pooling, expenses, investment gains and losses, capital requirements, and claims; an individual policy's nominal return is not equivalent to portfolio margin. For a social interpretation, protection against early death can have value even when no death claim occurs in one realized household history.
Sensitivity results from the teaching model
The 20-year teaching model permits controlled tests without pretending to reproduce a market. Under q=0.002 and D=M=USD 100,000, the net annual premium rises from approximately USD 3,345.79 at a 4% discount rate to USD 3,725.04 at 3% and USD 4,141.66 at 2%. The increase reflects the higher present value of long-horizon obligations when discounting becomes less favorable. Under a 3% rate, changing the hypothetical annual mortality from q=0.001 to q=0.004 increases the required net premium from approximately USD 3,668.95 to USD 3,838.18 because earlier payment of the equal death sum raises discounted expected benefit cost. These results are arithmetic implications of the specified model.
| Hypothetical effective annual discount | Hypothetical annual mortality | Net annual equivalence premium (USD) |
|---|---|---|
| 2% | 0.002 | 4,141.66 |
| 3% | 0.001 | 3,668.95 |
| 3% | 0.002 | 3,725.04 |
| 3% | 0.004 | 3,838.18 |
| 4% | 0.002 | 3,345.79 |
The results should be interpreted jointly. A fall in discount rate generally increases the cost of a long-dated fixed maturity guarantee in this simple structure. A higher death rate can either accelerate payment or reduce the probability of a larger maturity benefit. In the numerical case, death and maturity amounts coincide, so acceleration dominates. If D is much lower than M, a different net mortality sensitivity can arise. This is a conditional theoretical result that should be stress-tested with the actual benefit schedule instead of stated as a universal prediction.
An explicit counterfactual comparison
Consider a household choosing between a combined endowment with fixed death and survival amounts and two separable financial arrangements: a term life policy plus a separately funded savings asset. The combined structure can reduce operational fragmentation and impose a commitment schedule. Separate arrangements may allow more independent changes in coverage, investment risk, and liquidity. Neither arrangement dominates in all preference or cost settings. Relevant differences include acquisition and administrative expenses, tax law, guaranteed interest, insurer credit and resolution risks, access to funds, mortality underwriting, investment opportunities, surrender consequences, and whether insurance needs disappear before savings goals mature.
A credible comparative design would hold constant the death benefit schedule and intended future saving goal, then calculate total after-cost outcomes across standardized mortality, return, premium-payment, and lapse scenarios. An evaluation that holds only the nominal premium equal would conflate the cost of insurance protection and accumulation. Singapore's comparison of term and endowment features provides an educational product taxonomy, but no universal dominance conclusion. The original analytic conclusion is an identification rule: compare the entire state-contingent cash-flow set under common assumptions and legally enforceable guarantee states.
Observational studies and falsifiable hypotheses
A future microdata study could test whether endowment policies with lower early surrender values exhibit greater persistence among households with limited liquid resources, after controlling for income, issue age, adviser channel, contract design, and selection effects. Another could test whether bonus disclosure quality predicts the difference between projected and realized maturity values, conditional on underlying investment performance. A third could compare policyholder outcomes under guaranteed nonparticipating designs and participating designs with similar expected initial premiums. All three would need measures of the quality and timing of disclosures, survival and termination event records, and clear treatment of selection into contract type.
A fourth study could test how a duration mismatch between asset portfolios and maturity obligations affects profit volatility and liquidity stress when rates change. A fifth could test whether paid-up protection changes lapse behavior for long-running contracts. An event-study approach around regulatory changes would require careful assessment of other contemporaneous reforms and contractual grandfathering, rather than attributing all changes in sales or claims to one new rule. Such research questions follow from the verified regulatory and product evidence; they are proposals for ordinary empirical examination and not new proprietary models or doctrines.
Error sources and sensitivity controls
Several common errors materially distort endowment analysis. First, benefit illustrations may omit the distinction between the guaranteed base and uncertain bonuses. Second, a quoted maturity target may be mistaken for a legally enforceable sum. Third, future values may be compared without adjusting for premium timing or the cost of mortality cover. Fourth, cash surrender value may be used as a proxy for actuarial reserve or asset share even though each has a separate purpose. Fifth, a real fund's gross return may be compared against a policyholder's after-expense return without reconciling charges. Sixth, survival selection may be ignored when analyzing only matured policies.
A robust empirical protocol documents contract version, underwriting class, mortality and discount basis, actual cash-flow dates, currency, inflation treatment, guarantee status, fund performance, lapse assumptions, and the denominator for reported outcomes. It then checks records against issued policy forms, reconciles aggregate cash flows, tests sensitivity to mortality and interest paths, and reports confidence intervals and data exclusions where estimates are used. The documentary sources in this study support those controls as analytically necessary; this dossier does not claim to have executed a portfolio backtest or statistical causal identification.
Scientific Synthesis and Design Consequences
What the original analysis establishes
The combined endowment is best understood as an architecture of timed contingent obligations. The death promise addresses an adverse event before the horizon; the survival promise addresses a planned need at the horizon. Their combination causes the policy to respond differently to mortality, interest, lapse, and investment experience than a pure death policy or ordinary savings account. The joint cash-flow expression proves the separation mathematically. The primary contracts show that the separation persists in actual wording through different death and maturity definitions. Regulatory materials show that it must also persist in valuation and consumer explanation.
Five integrated findings follow from the evidence. The first is that contract classification should begin with payoffs rather than marketing terms. The second is that the cost of a fixed maturity benefit is heavily dependent on long-horizon discounting and survival assumptions, while death protection changes payment timing. The third is that surrender, paid-up options, loans, and installment settlements alter the timing and legal availability of value, so an initial benefit promise is incomplete without its option schedule. The fourth is that participating bonuses create a layered guarantee structure, making illustrated values and vested rights economically different. The fifth is that regulatory supervision spans classification, product governance, solvency, disclosure, and remedies; those functions do not collapse into a single measurement of returns.
A consistent comparison discipline
A rigorous comparison of two endowments can proceed through a sequence of documented analytical questions. What events trigger payment? Who receives the payment? What is the contractual date? What is guaranteed, vested, discretionary, or conditional? What happens on early death, lapse, paid-up status, surrender, loan, and settlement election? Which premium and expense paths fund the promises? Which assets and guarantees bear interest and market risk? Which supervisory and legal system determines enforceability and relief? What data are necessary to distinguish expected and realized outcomes?
This discipline is a synthesis of existing actuarial, contractual, and regulatory reasoning, not a newly instituted theoretical system. It prevents a frequent methodological error: treating a displayed projected maturity amount as though it had the same status as a guaranteed insured payment. It also encourages more meaningful comparison of household suitability, insurer liability, and product conduct without converting any one of them into a surrogate for the others.
Institutional consequences
For insurers, coherent maturity design requires contract terms, underwriting, premium rates, asset-liability decisions, bonus governance, administration, and policyholder communication to use compatible assumptions. A product can pass a pricing test under one set of assumptions yet create consumer harm when sales communication selectively highlights favorable projections. It can be legally clear but financially vulnerable to adverse reinvestment rates. Conversely, substantial guaranteed maturity value may offer useful planning certainty while imposing costs that should be transparently compared with other arrangements.
For supervisors, endowment protection includes both the ability to pay the long-dated obligation and the fairness of how the product is designed, illustrated, sold, administered, and terminated. The International Association of Insurance Supervisors' 2025 fair-treatment application paper locates fair customer treatment throughout a product's lifecycle. For researchers, the most valuable future work lies in matched policy-level data on guarantees, bonuses, persistency, and actual benefits, alongside comparable legal classifications. The international source comparison warrants this research agenda but does not supply a cross-national causal estimate.
Conclusion
Endowment insurance joins a death-contingent promise with a survival-contingent maturity obligation inside a finite contractual term. Its financial structure can be decomposed exactly for a stipulated mortality and discount basis, and its premiums and prospective reserves depend on the timing and size of both payments. A guaranteed maturity amount is an enforceable promise under the governing contract, while a projected bonus-inclusive amount remains dependent on its declared conditions. Surrender value, paid-up rights, loans, and settlement elections determine what the policyholder may actually receive before or after maturity and influence both consumer welfare and insurer cash flows.
The international primary evidence supports a comparative conclusion: robust design needs simultaneous consistency between legal wording, actuarial pricing, liability measurement, guarantee allocation, and disclosure. The U.S. classification and illustration materials, EU prudential and distribution rules, Indian product and surrender provisions, Singapore consumer education, and UK complaint evidence illuminate different portions of the same design problem. Their differences are substantive jurisdictional facts, rather than obstacles to a shared scientific description of contingent payoffs.
The numerical model demonstrates the mechanics of long-horizon maturity obligations without claiming actual pricing or investment performance. The next empirical step is to connect actual issued policy forms to insured-life exposure, premium and benefit records, surrender behavior, investment experience, and outcomes under adverse scenarios. These conclusions are original analytical synthesis within the established disciplines of insurance economics, actuarial valuation, insurance regulation, and consumer protection. They introduce no new doctrine and make no priority claim of scientific discovery.
References
Actuarial Standards Board. (2024). Actuarial Standard of Practice No. 24: NAIC Life Insurance Illustrations Model Regulation (revised September 2024; effective December 1, 2024). https://www.actuarialstandardsboard.org/asops/asop-24-naic-life-insurance-illustrations-model-regulation-024-217/
Actuarial Standards Board. (2021). Actuarial Standard of Practice No. 2: Nonguaranteed Elements for Life Insurance and Annuity Products. https://www.actuarialstandardsboard.org/asops/asop-no-2-nonguaranteed-elements-for-life-insurance-and-annuity-products/
European Insurance and Occupational Pensions Authority. (n.d.). Solvency II Single Rulebook: Article 77, Calculation of Technical Provisions. https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2160_en
European Insurance and Occupational Pensions Authority. (n.d.). Solvency II Single Rulebook: Article 79, Valuation of Financial Guarantees and Contractual Options. https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2167_en
European Insurance and Occupational Pensions Authority. (n.d.). Delegated Regulation (EU) 2015/35: Article 32, Contractual Options and Financial Guarantees. https://www.eiopa.europa.eu/rulebook/solvency-ii-single-rulebook/article-2445_en
European Insurance and Occupational Pensions Authority. (n.d.). Insurance Distribution Directive Single Rulebook: Article 25, Product Oversight and Governance. https://www.eiopa.europa.eu/rulebook/idd-insurance-distribution-directive/article-2643_en
European Insurance and Occupational Pensions Authority. (2024). Delegated Regulation (EU) 2017/2358: Article 7, Product Monitoring and Review. https://www.eiopa.europa.eu/rulebook/idd-insurance-distribution-directive/article-2717_en
European Parliament and Council of the European Union. (2016; consolidated 2024). Directive (EU) 2016/97 on Insurance Distribution. https://eur-lex.europa.eu/eli/dir/2016/97/2024-10-09/eng
Financial Ombudsman Service. (n.d.). Savings Endowments: How We Resolve Complaints. https://www.financial-ombudsman.org.uk/consumers/complaints-can-help/investments/savings-endowments
Financial Ombudsman Service. (2021). Decision DRN-2724950: Complaint Concerning a Mortgage Endowment Policy. https://www.financial-ombudsman.org.uk/decision/DRN-2724950.pdf
IFRS Foundation. (2023). IFRS 17 Insurance Contracts (standard effective for annual reporting periods beginning on or after January 1, 2023). https://www.ifrs.org/issued-standards/list-of-standards/ifrs-17-insurance-contracts/
IFRS Foundation. (n.d.). IFRS 17 Insurance Contracts: Key Terms. https://www.ifrs.org/supporting-implementation/supporting-materials-by-ifrs-standards/ifrs-17/key-terms/
Insurance Regulatory and Development Authority of India. (2024). Insurance Regulatory and Development Authority of India (Insurance Products) Regulations, 2024, Gazette of India, Extraordinary, Part III, Section 4, March 22, 2024. https://www.actuariesindia.org/sites/default/files/inline-files/10.%20IRDAI%20Insurance%20Products%20Regulations%202024.pdf
International Association of Insurance Supervisors. (2025, July 7). Application Paper on Fair Treatment of a Wide Range of Consumers: Publication Announcement. https://www.iais.org/2025/07/iais-publishes-application-paper-on-fair-treatment-of-a-wide-range-of-consumers/
Life Insurance Corporation of India. (n.d.). Endowment Plans: Current Product Catalog. https://www.licindia.in/web/guest/endowment-plans
Life Insurance Corporation of India. (2025). LIC's New Endowment Plan, UIN 512N277V03: Policy Document, Parts A–G. https://originlic.licindia.in/documents/20121/1385382/Final%2BPolicy%2BDocument%2B_LIC%27s%2BNew%2BEndowment%2BPlan.pdf/353630dd-dada-cd7e-d3cf-5792ee3cb807?t=1751638574726
MoneySense (Singapore). (2026, July 2). Understanding Endowment Insurance. https://www.moneysense.gov.sg/understanding-endowment-insurance/
MoneySense (Singapore). (2026, July 2). Participating Versus Non-Participating Policies. https://www.moneysense.gov.sg/participating-versus-non-participating-policies/
MoneySense (Singapore). (2026). Life Insurance: Comparing Term and Bundled Products. https://www.moneysense.gov.sg/term-vs-whole-life/
National Association of Insurance Commissioners. (2026, March). Accounting Practices and Procedures Manual, Volume I, Statement of Statutory Accounting Principles No. 50, “Classifications of Insurance or Managed Care Contracts,” paragraph 12. https://content.naic.org/sites/default/files/publication-app-manual.pdf
National Association of Insurance Commissioners. (2026, January 8). Life Insurance Illustrations: Insurance Topics. https://content.naic.org/insurance-topics/life-insurance-illustrations
National Association of Insurance Commissioners. (n.d.). Life Insurance Illustrations Model Regulation, Model No. 582. https://content.naic.org/sites/default/files/model-law-582.pdf
National Association of Insurance Commissioners. (n.d.). Life Insurance: Insurance Topics. https://content.naic.org/insurance-topics/life-insurance
National Association of Insurance Commissioners. (n.d.). Life Insurance Buyer's Guide. https://content.naic.org/sites/default/files/publication-lig-lp-consumer-life.pdf
Yaari, Menahem E. (1965). “Uncertain Lifetime, Life Insurance, and the Theory of the Consumer.” The Review of Economic Studies, 32(2), 137–150. https://academic.oup.com/restud/article-abstract/32/2/137/1555438 (DOI: 10.2307/2296058; publisher bibliographic record and abstract-page metadata consulted; full text not accessed).